Prashant Kohli

Chief Executive Officer at Grace Therapeutics.

Raised on Grace Therapeutics filings

$15M

of $30M offered across 1 Form D filing

Company

Biotech · Princeton, NJ

IV treatment for a rare type of brain bleed

IV treatment for a rare type of brain bleed

Grace Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Feb 25, 2025	Equity	$15M/ $30M	Form D

Also named on Grace Therapeutics filings